Cancer In Those Who Have Never Smoked: New Insights From Bench To Bedside

Cancer In Those Who Have Never Smoked: New Insights From Bench To Bedside

Regular price
Conference Bundle: FREE
Member: $39.20 Non-Member: $49.00
Sale price
Conference Assistant: FREE
Member: $39.20
Regular price
Non-Member: $49.00
Sold out
Unit price
per 

Quantity

-

+

Session date: May 23, 2023

Lung cancer is a common cause of cancer mortality even in those who have never used tobacco. Taken alone, lung cancer in those who have never smoked (LCNS) is the seventh leading cause of cancer death in the United States. This seminar will explore how LCNS differs epidemiologically and molecularly from lung cancer associated with tobacco use. Speakers will unique risk factors, strategies to identify those at risk, and novel treatment approaches.

• Describe new findings on the genetic and epidemiologic underpinnings of cancer in those with no tobacco history
• Define new strategies for early detection of cancer in those with no tobacco smoking history
• Better counsel patients about risk factors for lung cancer beyond tobacco smoking

Qing Lan, MD, PhD, MPH
Christine Berg, MD
Pan-Chyr Yang, MD
Joan Schiller, MD
Elaine Shum, MD

Genomic Risks Behind Lung Adenocarcinoma in Those Who Have Never Smoked
Calculating Risk for Lung Cancer in Those Who Have Never Smoked
The TALENT Trial: Lung Cancer Screening in a Population with Very Low Rates of Tobacco Use
Air Pollution and Lung Cancer
New Directions in Treating Lung Cancer in Those Who Have Never Smoked